Table 1.
Patient and tumor characteristics (N=100)
| Characteristic | value |
|---|---|
| Age at primary diagnosis (years) | Median: 49 (range: 30-73) |
| Tumor diameter (cm) | Mean: 4.7 (4.7±1.8) |
| Tumor stage (FIGO stage*) | |
| IIB | 24 (24%) |
| IIIB | 70 (70%) |
| IVA | 6 (6%) |
| Histological type | |
| Squamous carcinoma | 100 (100%) |
| LN status | |
| negative | 45 (45%) |
| positive | 55 (55%) |
| Brachytherapy method | |
| Intracavitary | 48 (48%) |
| Combined intracavitary/interstitial | 52 (52%) |
| Brachytherapy Fractions | |
| 3-5 | 59 (59%) |
| 6-7 | 41 (41%) |
| Overall treatment time (days) | |
| <58 | 42 (42%) |
| ≥58 | 58 (58%) |
| Weekly cisplatin | |
| No | 5 (5%) |
| yes | 95 (95%) |
| Follow-up period (months) | Median: 46 (range: 3-107) |
*FIGO: International Federation of Gynecology and Obstetrics